Healthcare -
Biotechnology - NASDAQ - US
$ 30.64
5.36 %
$ 3.68 B
Market Cap
-10.6
P/E
RNA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities RNA - Avidity Biosciences, Inc.
93.9 M
LAST VALUE
-27.04%
2 YEAR CAGR
78.75%
5 YEAR CAGR
0.00%
10 YEAR CAGR